Published in J Mol Cell Cardiol on August 01, 1998
Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats. Arthritis Res Ther (2003) 1.29
Mitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure? Ann Intensive Care (2011) 0.98
Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases? Int J Biol Sci (2015) 0.87
Raxofelast, a hydrophilic vitamin E-like antioxidant, reduces testicular ischemia-reperfusion injury. Urol Res (2004) 0.82
Cardioprotective effects of N-hydroxyguanidine PR5 in myocardial ischaemia and reperfusion in rats. Br J Pharmacol (1999) 0.75
Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev (2001) 3.29
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med (1999) 3.08
Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology (2001) 1.99
Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat. Crit Care Med (2001) 1.55
Epidemiological and virological analysis of couples infected with hepatitis C virus. Gut (1999) 1.55
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart (2006) 1.53
Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury. Eur Respir J (2005) 1.49
Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease. Haematologica (1996) 1.42
QTLs for agronomic traits in the Mediterranean environment identified in recombinant inbred lines of the cross 'Arta' x H. spontaneum 41-1. Theor Appl Genet (2003) 1.41
Vascular endothelial growth factor induces brain erythropoietin expression? Funct Neurol (2006) 1.38
The rising of celiac disease at the sunset of puerperium. J Clin Gastroenterol (2001) 1.38
Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol (2000) 1.29
Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. Diabetes (2001) 1.25
Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia (2003) 1.21
Patterns of genetic diversity and linkage disequilibrium in a highly structured Hordeum vulgare association-mapping population for the Mediterranean basin. Theor Appl Genet (2009) 1.20
Inducible nitric oxide synthase-knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan. Am J Respir Crit Care Med (2000) 1.17
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. Hepatology (2000) 1.17
Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat. Crit Care Med (1999) 1.16
Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J Pineal Res (2001) 1.12
Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403. Br J Pharmacol (2001) 1.11
Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J (2000) 1.11
Quantitative trait loci associated with adaptation to Mediterranean dryland conditions in barley. Theor Appl Genet (2008) 1.11
Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol. Br J Pharmacol (2008) 1.10
17Beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat. Eur J Pharmacol (1997) 1.10
Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharmacol (1997) 1.10
Peptide sequencing by using a combination of partial acid hydrolysis and fast-atom-bombardment mass spectrometry. Biochem J (1986) 1.10
Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials. Clin Pharmacol Ther (2011) 1.10
Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats. Cardiovasc Res (2000) 1.09
Delta agent and hepatocellular carcinoma. Prog Clin Biol Res (1983) 1.08
Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages. Br J Pharmacol (2009) 1.08
Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic. Arthritis Rheum (2001) 1.08
Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics. Psychopharmacology (Berl) (2000) 1.08
Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat. Crit Care Med (1999) 1.08
Effect of cross-tolerance between endotoxin and TNF-alpha or IL-1beta on cellular signaling and mediator production. J Leukoc Biol (2001) 1.07
PreS and core gene heterogeneity in hepatitis B virus (HBV) genomes isolated from patients with long-lasting HBV chronic infection. Virology (1995) 1.06
Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia. Psychopharmacology (Berl) (2001) 1.05
Calpain inhibitor I reduces the development of acute and chronic inflammation. Am J Pathol (2000) 1.05
Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury. Brain Res (2000) 1.05
The protective role of endogenous estrogens in carrageenan-induced lung injury in the rat. Mol Med (2001) 1.03
Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock. Br J Pharmacol (1999) 1.03
Mixed model association scans of multi-environmental trial data reveal major loci controlling yield and yield related traits in Hordeum vulgare in Mediterranean environments. Theor Appl Genet (2011) 1.03
Recombinant AAV vector encoding human VEGF165 enhances wound healing. Gene Ther (2002) 1.02
Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats. J Pharmacol Exp Ther (1980) 1.02
Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. Hepatology (1997) 1.01
Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. J Clin Invest (1999) 1.01
Latency and reactivation of a precore mutant hepatitis B virus in a chronically infected patient. J Hepatol (1990) 1.01
Role of tumor necrosis factor-alpha in acute hypovolemic hemorrhagic shock in rats. Am J Physiol (1994) 1.00
Morphometric and neurophysiological analysis of skeletal muscle in paraplegic patients with traumatic cord lesion. Paraplegia (1991) 0.99
Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects. Ther Drug Monit (1993) 0.99
Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat. Gut (2001) 0.99
Pulse wave velocity and augmentation index, but not intima-media thickness, are early indicators of vascular damage in hypercholesterolemic children. Eur J Clin Invest (2010) 0.99
Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury. Br J Pharmacol (1999) 0.99
Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology (1997) 0.99
Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion. Br J Pharmacol (2001) 0.98
IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury. Cardiovasc Res (2000) 0.98
Early onset of breast carcinoma in African American women with poor prognostic factors. Am J Clin Oncol (1999) 0.98
Peroxynitrite-mediated DNA strand breakage activates poly (ADP-ribose) synthetase and causes cellular energy depletion in carrageenan-induced pleurisy. Immunology (1998) 0.98
Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate. Br J Pharmacol (2009) 0.97
Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005. Eur J Neurol (2007) 0.97
Protective effects of n-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat. FASEB J (2001) 0.96
Beneficial effects of n-acetylcysteine on ischaemic brain injury. Br J Pharmacol (2000) 0.96
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women. Arterioscler Thromb Vasc Biol (2001) 0.96
Role of IL-6 in the pleurisy and lung injury caused by carrageenan. J Immunol (1999) 0.96
Neuroprotective effects of Ginkgo biloba extract in brain ischemia are mediated by inhibition of nitric oxide synthesis. Life Sci (2000) 0.96
Beneficial effects of Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in carrageenan-induced pleurisy. Free Radic Biol Med (1999) 0.96
Raxofelast, a hydrophilic vitamin E-like antioxidant, stimulates wound healing in genetically diabetic mice. Surgery (2001) 0.96